Fundz

Thiogenesis Therapeutics reported raising $252,000 in an initial SEC Form D filing, from an offering of $252,000

PUBLIC · TTIPFDec 20, 2023

Amount Raised

$252,000

$252,000 sold, per SEC Form D (first sale Dec 15, 2023)

Round Type

Seed

TorontoOtherBiotechnology

Quick answer

Thiogenesis Therapeutics raised $252,000 in a Seed round, dated December 15, 2023. Thiogenesis Therapeutics is based in Toronto, Ontario, Canada.

How much did Thiogenesis Therapeutics raise?
Thiogenesis Therapeutics raised $252,000 in a Seed round on December 15, 2023.
What does Thiogenesis Therapeutics do?
Thiogenesis Therapeutics (TSXV: TTI) is developing New Chemical Entities (NCEs) that are novel thiol compounds with strong antioxidant and anti-inflammatory properties; and that have the potential to be used as new..
Where is Thiogenesis Therapeutics based and how big is it?
Thiogenesis Therapeutics is based in Toronto, Ontario, Canada.
Who are the decision-makers at Thiogenesis Therapeutics?
Fundz holds 1 contact at Thiogenesis Therapeutics, including the Executive Officer, Director. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as Thiogenesis Therapeutics that raised within 45 days of this round, from Fundz verified event records.

  • UniFAHS raised $1.4M (Seed) on January 29, 2024.
  • Biomakers raised $2.4M (Seed) on January 26, 2024.
  • Attralus raised $56M on January 26, 2024.
  • Aspira Women’s Health raised $6.5M on January 26, 2024.
  • RenovoRx raised $6.1M on January 26, 2024.
  • Calidi Biotherapeutics raised $1M on January 26, 2024.

Who to call at Thiogenesis Therapeutics, and when

A new round usually means Thiogenesis Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Thiogenesis Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Thiogenesis Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Thiogenesis Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Thiogenesis Therapeutics

Location

4 KING STREET WEST, SUITE 401

Toronto, Ontario, Canada

About

Thiogenesis Therapeutics (TSXV: TTI) is developing New Chemical Entities (NCEs) that are novel thiol compounds with strong antioxidant and anti-inflammatory properties; and that have the potential to be used as new therapeutic drugs for mitochondrial diseases including metabolic conditions like fatty liver disease, diabetes, etc. Oxidative stress and mitochondrial dysfunction are critical underlying features of mitochondrial diseases.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Thiogenesis Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsPatrice R., Executive Officer, Director hidden hidden hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Thiogenesis Therapeutics's next move

See what Strategic adds

Thiogenesis Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.